2O5D image
Deposition Date 2006-12-05
Release Date 2007-02-20
Last Version Date 2023-12-27
Entry Detail
PDB ID:
2O5D
Keywords:
VIRAL PROTEIN
Title:
Thiazolone-acylsulfonamides as novel HCV NS5B polymerase allosteric inhibitors: Convergence of structure-based drug design and X-ray crystallographic study
Biological Source:
Source Organism:
Hepatitis C virus (Taxon ID: 11103)
Host Organism:
Escherichia coli
Method Details:
Experimental Method:
X-RAY DIFFRACTION
Resolution:
2.20 Å
R-Value Free:
0.25
R-Value Work:
0.20
Space Group:
P 21 21 21
2O5D validation report
Macromolecular Entities
Protein Blast
Polymer Type:polypeptide(L)
Molecule:HCV
Chain IDs:A, B
Chain Length:576
Number of Molecules:2
Biological Source:Hepatitis C virus
UniProt ID:P26663 Pfam ID:PF00998 EC:3.4.21.98
Ligand Molecules
VR1
Primary Citation
Thiazolone-acylsulfonamides as novel HCV NS5B polymerase allosteric inhibitors: Convergence of structure-based drug design and X-ray crystallographic study.
Bioorg.Med.Chem.Lett. 17 1991 1995 (2007)
PMID: 17276060 DOI: 10.1016/j.bmcl.2007.01.024

Abstact

A novel series of thiazolone-acylsulfonamides were designed as HCV NS5B polymerase allosteric inhibitors. The structure based drug designs (SBDD) were guided by docking results that revealed the potential to explore an additional pocket in the allosteric site. In particular, the designed molecules contain moieties of previously described thiazolone and a newly designed acylsulfonamide linker that is in turn connected with a substituted aromatic ring. The selected compounds were synthesized and demonstrated low muM activity. The X-ray complex structure was determined at a 2.2A resolution and converged with the SBDD principle.

Legend

Protein

Chemical

Disease

Primary Citation of related structures
2O5D